Ascendia Pharmaceuticals

A specialty US CDMO providing custom formulation development and manufacturing, delivering sophisticated formulations to enhance bioavailability, solubility and stability while reducing toxicity through GRAS materials and four proprietary nanotechnologies — NanoSol, EmulSol, AmorSol and LipidSol. Following formulation selection and optimization, Ascendia can quickly scale up development programs to cGMP manufacturing of clinical materials, offering both aseptic and non-aseptic manufacturing for small molecules and biologics.